Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Himil Mahadevia, Pedro Luiz Serrano Uson Junior, Jing Wang, Mitesh Borad & Hani Babiker. (2024) An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer. Expert Opinion on Pharmacotherapy 25:1, pages 79-90.
Read now
Read now
Sayumi Yoshida, Zensho Ito, Machi Suka, Tsuuse Bito, Shin Kan, Takafumi Akasu, Masayuki Saruta, Masato Okamoto, Hiroaki Kitamura, Shuichi Fujioka, Takeyuki Misawa, Tadashi Akiba, Hiroyuki Yanagisawa, Haruo Sugiyama & Shigeo Koido. (2019) Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer. Cancer Investigation 37:9, pages 463-477.
Read now
Read now
Articles from other publishers (34)
Raquel Bodoque-Villar, David Padilla-Valverde, Lucía María González-López, José Ramón Muñoz-Rodríguez, Javier Arias-Pardilla, Clara Villar-Rodríguez, Francisco Javier Gómez-Romero, Gema Verdugo-Moreno, Francisco Javier Redondo-Calvo & Leticia Serrano-Oviedo. (2023) The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer. World Journal of Surgical Oncology 21:1.
Crossref
Crossref
Kunlong Duan, Huihui Zhou, Wanni Xu, Li Yang, Dong Fan, Zhilin Zhang, Jun Zhang & Ming Yu. (2023) Evaluation of Tumor Fibrosis in Pancreatic Ductal Adenocarcinoma by 2-D Shear Wave Elastography: A Pilot Study. Ultrasound in Medicine & Biology 49:9, pages 2119-2125.
Crossref
Crossref
Kailing Yang, Xiaojia Li & Keping Xie. (2023) Senescence program and its reprogramming in pancreatic premalignancy. Cell Death & Disease 14:8.
Crossref
Crossref
Nicole Lintern, Andrew M. Smith, David G. Jayne & Yazan S. Khaled. (2023) Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma. Cancers 15:16, pages 4135.
Crossref
Crossref
Xue Wang, Jin Niu, Shuo Qian, Shichen Shen, Robert M. Straubinger & Jun Qu. (2023)
Species-Deconvolved Proteomics for
In Situ
Investigation of Tumor-Stroma Interactions after Treatment of Pancreatic Cancer Patient-Derived Xenografts with Combined Gemcitabine and Paclitaxel
. Journal of Proteome Research 22:7, pages 2436-2449.
Crossref
Crossref
Michela Roberto, Giulia Arrivi, Mattia Alberto Di Civita, Giacomo Barchiesi, Emanuela Pilozzi, Paolo Marchetti, Daniele Santini, Federica Mazzuca & Silverio Tomao. (2023) The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets. Frontiers in Oncology 13.
Crossref
Crossref
Jérémy Nigri, Julie Leca, Sarah-Simha Tubiana, Pascal Finetti, Fabienne GuillaumondSébastien Martinez, Sophie LacJuan L. IovannaStéphane Audebert, Luc Camoin, Sophie VasseurFrançois Bertucci & Richard Tomasini. (2022) CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness. Science Signaling 15:745.
Crossref
Crossref
Hao Yang, Julia Messina-Pacheco, Andrea Liliam Gomez Corredor, Alex Gregorieff, Jun-li Liu, Ali Nehme, Hamed S. Najafabadi, Yasser Riazalhosseini, Bo Gao & Zu-hua Gao. (2022) An integrated model of acinar to ductal metaplasia-related N7-methyladenosine regulators predicts prognosis and immunotherapy in pancreatic carcinoma based on digital spatial profiling. Frontiers in Immunology 13.
Crossref
Crossref
Julian Götze, Christine Nitschke, Faik G. Uzunoglu, Klaus Pantel, Marianne Sinn & Harriet Wikman. (2022) Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Petros X. E. Mouratidis & Gail ter Haar. (2022) Latest Advances in the Use of Therapeutic Focused Ultrasound in the Treatment of Pancreatic Cancer. Cancers 14:3, pages 638.
Crossref
Crossref
Michela Cortesi, Michele Zanoni, Francesca Pirini, Maria Maddalena Tumedei, Sara Ravaioli, Ilario Giovanni Rapposelli, Giovanni Luca Frassineti & Sara Bravaccini. (2021) Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight. International Journal of Molecular Sciences 23:1, pages 254.
Crossref
Crossref
Fiona O'Connell & Jacintha O'Sullivan. (2021) Help or hindrance: The obesity paradox in cancer treatment response. Cancer Letters 522, pages 269-280.
Crossref
Crossref
Sonia Perales, Carolina Torres, Cristina Jimenez-Luna, Jose Prados, Joaquina Martinez-Galan, Jose Manuel Sanchez-Manas & Octavio Caba. (2021) Liquid biopsy approach to pancreatic cancer. World Journal of Gastrointestinal Oncology 13:10, pages 1263-1287.
Crossref
Crossref
Shun Wang, Yan Zheng, Feng Yang, Le Zhu, Xiao-Qiang Zhu, Zhe-Fang Wang, Xiao-Lin Wu, Cheng-Hui Zhou, Jia-Yan Yan, Bei-Yuan Hu, Bo Kong, De-Liang Fu, Christiane Bruns, Yue Zhao, Lun-Xiu Qin & Qiong-Zhu Dong. (2021) The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Dong Yu, Tengjiao Wang, Dong Liang, Yue Mei, Wenbin Zou & Shiwei Guo. (2021) The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data. Frontiers in Oncology 11.
Crossref
Crossref
Konstantin Schlick, Dominik Kiem, Florian Huemer, Daniel Neureiter, Lukas Weiss & Richard Greil. (2021) Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients. Technology in Cancer Research & Treatment 20, pages 153303382110421.
Crossref
Crossref
Mitchell S. von Itzstein, Michael C. Burke, Rolf A. Brekken, Todd A. Aguilera, Herbert J. Zeh & Muhammad Shaalan Beg. (2020) Targeting TAM to Tame Pancreatic Cancer. Targeted Oncology 15:5, pages 579-588.
Crossref
Crossref
Gemma van Duijneveldt, Michael D.W. Griffin & Tracy L. Putoczki. (2020) Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Clinical Science 134:16, pages 2091-2115.
Crossref
Crossref
Jeffrey Norton, Deshka Foster, Malini Chinta, Ashley Titan & Michael Longaker. (2020) Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment. Cancers 12:5, pages 1347.
Crossref
Crossref
Daniel C. Maneval, Chris L. Caster, Celine Derunes, Kenneth W. Locke, Mann Muhsin, Sybille Sauter, Rose E. Sekulovich, Curtis B. Thompson & Michael J. LaBarre. 2020. Polymer-Protein Conjugates. Polymer-Protein Conjugates
175
204
.
Jin Woo Yoo & James J. Farrell. 2020. Encyclopedia of Gastroenterology. Encyclopedia of Gastroenterology
30
38
.
Karina Juhl, Anders Christensen, Niclas Rubek, Kirstine Kim Schmidt Karnov, Christian von Buchwald & Andreas Kjaer. (2019)
Improved surgical resection of metastatic pancreatic cancer using uPAR targeted
in vivo
fluorescent guidance: comparison with traditional white light surgery
. Oncotarget 10:59, pages 6308-6316.
Crossref
Crossref
Rubin Jiao, Kevin J. H. Allen, Mackenzie E. Malo, Muath Helal, Zewei Jiang, Karishma Smart, Susan V. Buhl, David Rickles, Ruth A. Bryan & Ekaterina Dadachova. (2019) Evaluation of novel highly specific antibodies to cancer testis antigen Centrin‐1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer. Cancer Medicine 8:11, pages 5289-5300.
Crossref
Crossref
Andreas Henriksen, Anne Dyhl-Polk, Inna Chen & Dorte Nielsen. (2019) Checkpoint inhibitors in pancreatic cancer. Cancer Treatment Reviews 78, pages 17-30.
Crossref
Crossref
Leo L. Cheng. (2019) Response to re: Metabolomic prostate cancer fields in HRMAS MRS‐profiled histologically benign tissue vary with cancer status and distance from cancer. Dinges et al., NBM 2019. NMR in Biomedicine 32:8.
Crossref
Crossref
Yi Lu, Chujun Li, Honglei Chen & Weijie Zhong. (2018) Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods. Molecular Biology Reports 45:6, pages 1799-1807.
Crossref
Crossref
Priscilla Cascetta, Alessandro Cavaliere, Geny Piro, Lorena Torroni, Raffaela Santoro, Giampaolo Tortora, Davide Melisi & Carmine Carbone. (2018) Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance. International Journal of Molecular Sciences 19:11, pages 3331.
Crossref
Crossref
Douglas E. Biancur & Alec C. Kimmelman. (2018) The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1870:1, pages 67-75.
Crossref
Crossref
David B. Zhen, Andrew Coveler, Silvia Zanon, Michele Reni & E. Gabriela Chiorean. (2018) Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma. Seminars in Oncology 45:3, pages 107-115.
Crossref
Crossref
Dingyuan Hu, Daniel Ansari, Krzysztof Pawłowski, Qimin Zhou, Agata Sasor, Charlotte Welinder, Theresa Kristl, Monika Bauden, Melinda Rezeli, Yi Jiang, György Marko-Varga & Roland Andersson. (2018) Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. Oncotarget 9:11, pages 9789-9807.
Crossref
Crossref
Daniel Ansari, Helmut Friess, Monika Bauden, Johan Samnegård & Roland Andersson. (2018) Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment. Oncotarget 9:5, pages 6644-6651.
Crossref
Crossref
Nikolaj Nielsen, Kateryna Kondratska, Tobias Ruck, Benedikt Hild, Ilya Kovalenko, Sandra Schimmelpfennig, Jana Welzig, Sarah Sargin, Otto Lindemann, Sven Christian, Sven G. Meuth, Natalia Prevarskaya & Albrecht Schwab. (2017) TRPC6 channels modulate the response of pancreatic stellate cells to hypoxia. Pflügers Archiv - European Journal of Physiology 469:12, pages 1567-1577.
Crossref
Crossref
Nicola Gaianigo, Davide Melisi & Carmine Carbone. (2017) EMT and Treatment Resistance in Pancreatic Cancer. Cancers 9:12, pages 122.
Crossref
Crossref
Leslie E. Oldfield, Ashton A. Connor & Steven Gallinger. (2017) Molecular Events in the Natural History of Pancreatic Cancer. Trends in Cancer 3:5, pages 336-346.
Crossref
Crossref